Busschots D, Bielen R, Koc ÖM, Heyens L, Verrando R, de Galocsy C, Van Steenkiste C, Nevens F, Midgard H, Dalgard O, Robaeys G(2021) Hepatitis C reinfection in former and active injecting drug users in Belgium Harm Reduct J, 18(1), 102 DOI 10.1186/s12954-021-00552-x, PubMed 34641896
Dalgard O, Midgard H, Kielland KB(2021) Hepatitis C in Iceland: a milestone for global elimination Lancet Gastroenterol Hepatol, 6(8), 599-600 DOI 10.1016/S2468-1253(21)00182-5, PubMed 34171268
Fadnes LT, Aas CF, Vold JH, Leiva RA, Ohldieck C, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgård O, Vickerman P, Midgard H, Løberg EM, Johansson KA, INTRO-HCV Study Group(2021) Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV) PLoS Med, 18(6), e1003653 DOI 10.1371/journal.pmed.1003653, PubMed 34061883
